Cyto-Pathology Classification

986
Case 0002M : two partial karyotypes with a normal chromosome 9 pair, a der(9;18)and a normal chromosome 18 and arrow)
Comments
Both the cases described in this study were followed for >5 years. Case 0001M, had thrombocytosis and could not tolerate Interferon or Hydrea treatment and hence was treated with Busulfan. The patient was positive for JAK2 mutation (on chromosome 9). A recent study was to rule out transformation of MPN as there was myelofibrosis, splenomegaly and apparent progression of the disease. The der(9;18) was first identified in the stem line and a sideline had partial deletion of chromosome 13q. Case 0002M was a MDS case with a der(9;18) detected in the initial study and again when the patient was suspected to be transforming >5 years later. This patient had very little symptoms and was not treated. In this report for the first time a long standing MDS case was found to have the der(9;18) at initial diagnosis and after over 5 years . Others reported with der(9;18)(n 7) had PV (n 3) or post PV myelofibrosis (n 4) and one had sAML after ET. The JAK2V617F is a gain in function mutation on chromosome 9. Hence, the extra copy of 9p may exacerbate the MPN as observed in 0001M case. The patient had splenomegaly and also myelofibrosis when the patient was found with the der(9;18). Der(9;18) is the sole abnormality in most reported cases, balanced translocations or complex aberrant karyotypes were reported as additional abnormalities. Our patient had del(13) in a sideline and this abnormality is observed in MPN. Among the 9 patients with der(9;18) two arose post treatment (present case 0001M and Andrieux et al 2003) . and the other were at diagnosis. The der(9;18) supports progression of the disease in case 0001M but in case 0002M with MDS it reappears when there is suspicion of transformation and its role is less uncertain.
